Skip to main content

Medical Research Future Fund (MRFF)

National funding to support inspiring medical and health research
Find key dates and links to MRFF funding schemes, as well as contact details of our specialist staff who can help you with the funding process.

The Medical Research Future Fund (MRFF) is a $20 billion investment in the health of Australians. Funds support researchers to make the next big medical discoveries that will benefit all Australians. It represents the single largest boost to research funding in Australia’s history.

MRFF strategies are complementary but separate to those addressed by the National Health and Medical Research Council (NHMRC) and are intended to complement other investments by state and territory governments, as well as the private sector.

Following a national consultation process involving community and sector participation, the Australian Medical Research Advisory Board (AMRAB), in conjunction with the federal government, released the 2018-2020 Medical Research Future Fund (MRFF) priorities, which will guide and inform future government decisions.

MRFF strategic platforms

The MRFF plans to transform health and medical research through 6 strategic platforms:

  1. Strategic and International Horizons: support stronger partnerships between researchers, healthcare professionals, governments and the community. This will help position Australia as a leader in significant global research, such as tackling antimicrobial resistance.
  2. Data and Infrastructure: make better use of existing data and infrastructure to help improve our health and medical research.
  3. Health Services and Systems: strengthen our health services and systems research to make healthcare more efficient and affordable.
  4. Capacity and Collaboration: develop the skills of researchers and healthcare professionals and encourage collaboration across health and medical research disciplines and sectors.
  5. Trials and Translation: support new and existing clinical trial networks to guide the development of new drugs and devices, new models of care, and improved clinical practice.
  6. Commercialisation: Support researchers to find a commercial partner or investor to help turn their discoveries into every day realities.

Some funding disbursements are expected to be made through competitive grants processes and targeted calls administered by the Department of Health, NHMRC, or other independent bodies.

Current funding opportunities

Genomic Health Futures Mission- Project Grant Opportunity
Applications open: 26 March 2019
Minimum data deadline: N/A
Applications close: 21 June 2019
Contact: Sherridan Blackman

BioMedTech Horizons Program (BMTH) – Expression of Interest Round 2
This EOI is required for invitation to a full application. Areas of funding are in Ophthalmology, Cardiovascular, Orthopaedics and Emergency Medicine/Trauma
Application open: Now
Minimum data deadline: N/A
Applications close: 15 July 2019
Contact: Duncan MacInnis

Genomic Health Futures Mission (Flagship) - Pathogen Genomics Grant Opportunity (forecast)
Applications open: 16 July 2019
Minimum data deadline: N/A
Applications close: 12 September 2019
Contact: Research Support team

International Clinical Trial Collaborations Program
2019 – Peer Review Cycle 2
Minimum data deadline: 31 July 2019
Applications close: 15 August 2019
Contact: Anu George

2019 – Peer Review Cycle 3
Minimum data deadline: 20 November 2019
Applications close: 4 December 2019
Contact: Anu George

For strategic writing advice, contact Ed Hendriks, MRFF Development Manager.